The Fate of Leached Di(2-Ethylhexyl)Phthalate in Patients Undergoing Capd Treatment

Abstract

Objectives To evaluate the degree of exposure to and the fate of di(2-ethylhexyl)phthalate (DE HP) and its major derivatives mono(2-ethylhexyl)phthalate (ME HP), 2-ethylhexanol (2-EH), and phthalic acid (PA) in patients undergoing regular continuous ambulatory peritoneal dialysis (CAPD) during a 4-hour dwell period. Design Prospective, controlled. Setting Teaching hospital, Department of Nephrology. Participants Seven elderly patients on stable CAPD using Fresenius instruments and dialysate and 6 agematched healthy controls. Interventions During a routinely performed peritoneal equilibration test (PET), blood and dialysate samples were drawn before and 120 and 240 min after the dwell was started. In addition, blood samples were taken from a group of volunteers participating in a pharmacological study. Measurements Quantitative analysis of DE HP and its hydrolysis products was performed by selected ion-monitoring gas chromatography/mass spectrometry, operating the mass spectrometer in a combined positive and negative ion chemical ionization mode. Results Serum concentrations of DE HP and PA were significantly higher in patients (median: 0.079 I1g/mL, range: 0.032 -0.210 I1g/mL; and 0.167 I1g/mL, range: 0.097 0.231 I1g/mL, respectively) than in controls [0.0195 I1g/mL, range: 0.016 -0.025I1g/mL (p = 0.0027) and 0.0120 I1g/mL, range: 0.006 -0.034I1g/mL (p = 0.0026), respectively]. Concentration of ME HP in the fluid of CAPD bags prior to use was four times higher than that of the parent compound. During the first 4 hours of dwell time, the concentrations of ME HP and 2-EH in dialysate consistently decreased from 0.177 (range: 0.137 -0.239119/ mL) to 0.022 I1g/mL (range: 0.005 -0.058 I1g/mL) (p = 0.017), and from 0.087 (range: 0.075 -0.097I1g/mL) to 0.05 I1g/mL (range: 0.023 0.064I1g/mL) (p = 0.017), respectively, while the concentration of DE HP remained stable. Remarkably high concentrations of PA (0.129 I1g/mL; range: 0.038 -0.466 I1g/mL) were found in CAPD bags prior to use, and these concentrations tended to increase during dwell time, without statistical significance, however (0.135I1g/mL; range: 0.073 -0.659I1g/mL, p = 0.062). Conclusions Patients on CAPD are regularly exposed to considerable amounts of phthalic ester derivatives, mainly to MEHPand PA. ME HP seems to bewellabsorbed by the peritoneal membrane. The long-term effects of this exposure remain to be elucidated.

Microplastic in Aquatic Ecosystems

“…The impact of MP on humans is not yet fully understood, however, many chemicals that are used in plastic production and are known to be toxic, for example, bisphenol A (BPA), polybrominated diphenyl ethers (PBDE), and tetrabromobisphenol (TBBPA) have already been detected in human tissues and biological fluids . It has also been reported that additives, for example, di(2‐ethylhexyl)phthalate (DEHP), can leach from medical supplies made of PVC and accumulate in the blood of haemodialysis patients . Moreover, the presence of MP in seafood, for example, bivalves cultured for human consumption, has already been shown .…”

The male reproductive system and its susceptibility to endocrine disrupting chemicals

“…High concentrations of DEHP have been measured in blood of patients undergoing dialysis, caused by migration of the plasticizer from plastic medical devices (Pollack et al. , 1985; Mettang et al. , 1996).…”

Mikroplastik in aquatischen Ökosystemen

“…Von vielen Chemikalien, die in der Kunststoffproduktion eingesetzt werden, ist jedoch bekannt, dass sie toxisch sind, wie Bisphenol A (BPA), polybromierte Diphenylether (PBDE) und Tetrabrombisphenol A (TBBPA), die bereits in menschlichem Gewebe und Körperflüssigkeiten nachgewiesen wurden . Es wurde weiterhin berichtet, dass Additive wie Di(2‐ethylhexyl)phthalat (DEHP) aus medizinischem Zubehör, das aus PVC besteht, austreten kann und sich im Blut von Hämodialyse‐Patienten anreichert . Weiterhin wurde gezeigt, dass MP in Meeresfrüchten, z.…”